Austin W. Marxe & David M. Greenhouse’s iRadimed IRMD Stock Holding History

Austin W. Marxe & David M. Greenhouse’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$1.47M	Buy	+210,285	New	+$1.9M	0.2%	103

Other funds holding IRMD

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Gruber & McBaine Capital Management San Francisco, California $369M AUM 12.23% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return

Connors Investor Services Wyomissing, Pennsylvania $1.08B AUM 31.31% 1-Year Est. Return

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Austin W. Marxe & David M. Greenhouse's IRMD Position: Q3 2014 in Review

Austin W. Marxe & David M. Greenhouse opened a new position in iRadimed (IRMD) in Q3 2014: 210,285 shares worth $1.47M. The stake represents 0.2% of the portfolio and ranks #103 among its holdings.

17 funds tracked by Wall St. Rank hold IRMD as of Q3 2014.

Austin W. Marxe & David M. Greenhouse held 210,285 shares of iRadimed worth $1.47M as of Q3 2014.
iRadimed was a new Austin W. Marxe & David M. Greenhouse position in Q3 2014.
iRadimed made up 0.2% of Austin W. Marxe & David M. Greenhouse's portfolio in Q3 2014, its #103 holding.
17 funds tracked by Wall St. Rank held iRadimed as of Q3 2014.

Based on Austin W. Marxe & David M. Greenhouse's 13F filing for Q3 2014, filed 14 Nov 2014.